Dr John S Tregoning

About Dr John S Tregoning

Dr John S Tregoning, With an exceptional h-index of 41 and a recent h-index of 32 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of Respiratory Infections, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Robust and sensitive amplicon-based whole-genome sequencing assay of respiratory syncytial virus subtype A and B

IL-1α is required for T cell driven weight loss after respiratory viral infection

Optimising a linear ‘Doggybone’DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen

Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines

Propylene glycol inactivates respiratory viruses and prevents airborne transmission

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague

LION: Taming RNA vaccine inflammation

Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii

Dr John S Tregoning Information

University

Position

___

Citations(all)

7839

Citations(since 2020)

4627

Cited By

4659

hIndex(all)

41

hIndex(since 2020)

32

i10Index(all)

75

i10Index(since 2020)

65

Email

University Profile Page

Google Scholar

Dr John S Tregoning Skills & Research Interests

Respiratory Infections

Immunology

Top articles of Dr John S Tregoning

Title

Journal

Author(s)

Publication Date

Robust and sensitive amplicon-based whole-genome sequencing assay of respiratory syncytial virus subtype A and B

Microbiology Spectrum

Tiina Talts

Lucy G Mosscrop

David Williams

John S Tregoning

Whitney Paulo

...

2024/2/27

IL-1α is required for T cell driven weight loss after respiratory viral infection

Mucosal Immunology

Ziyin Wang

Leah F Cuthbertson

Chubicka Thomas

Hadijatou J Sallah

Lucy G Mosscrop

...

2024/2/19

Optimising a linear ‘Doggybone’DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen

Discovery Immunology

Robert F Cunliffe

David C Stirling

Ilaria Razzano

Valarmathy Murugaiah

Emanuele Montomoli

...

2024/1/3

Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines

Molecular Therapy-Nucleic Acids

John S Tregoning

David C Stirling

Ziyin Wang

Katie E Flight

Jonathan C Brown

...

2023/3/14

Propylene glycol inactivates respiratory viruses and prevents airborne transmission

EMBO Molecular Medicine

Christine T Styles

Jie Zhou

Katie E Flight

Jonathan C Brown

Charlotte Lewis

...

2023/12/7

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague

Frontiers in Microbiology

Robin John Shattock

Voahangy Andrianaivoarimanana

Paul F McKay

Lovasoa Nomena Randriantseheno

Valarmathy Murugaiah

...

2023/11/2

LION: Taming RNA vaccine inflammation

Molecular Therapy

John S Tregoning

2023/9/6

Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii

Journal of Infection

Sophie L Higham

Stephen Baker

Katie E Flight

Aishwarya Krishna

Paul Kellam

...

2023/6/1

A Rhinovirus-A16 VP0 Vaccine Induces Homotypic Humoral and Cellular Immunity, and Following Heterotypic Rhinovirus-A01 Infection, Accelerates Virus Clearance and Induces Cross …

CJ Pyle

ND Patel

Z Wang

JS Tregoning

P Hamblin

...

2023/5

Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice

Molecular Therapy-Nucleic Acids

Ziyin Wang

Egon J Jacobus

David C Stirling

Stefanie Krumm

Katie E Flight

...

2023/12/12

Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets

Oxford open immunology

PF McKay

J Zhou

R Frise

AK Blakney

CR Bouton

...

2022/1/1

Levels of influenza A virus defective viral genomes determine pathogenesis in the BALB/c mouse model

Journal of Virology

Rebecca Penn

John S Tregoning

Katie E Flight

Laury Baillon

Rebecca Frise

...

2022/11/9

Respiratory syncytial virus after the SARS-CoV-2 pandemic—what next?

Lucy G Mosscrop

Thomas C Williams

John S Tregoning

2022/10

Group B Streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable

Clinical and Experimental Immunology

IL Haeusler

O Daniel

C Isitt

R Watts

L Cantrell

...

2022/8/1

Blocking T‐cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity

Immunology

Jamie FS Mann

Paul F McKay

Katja Klein

Joshua Pankrac

John S Tregoning

...

2022/3

FLU FIGHTERS: HOW CHILDREN WHO GET THE NASAL INFLUENZA VACCINE PROTECT OTHERS FROM FLU

How to Fight Harmful Microbial Bugs and Superbugs?

Alice Halliday

Mica Roan Tolosa-Wright

Aime Afua Boakye

John S Tregoning

2021/9/1

738 Resident memory airway T cells protect against RSV infection in the absence of antibody

Ekaterina Kinnear

Laura Lambert

Jacqueline McDonald

Hannah Cheeseman

Lisa Caproni

...

2021/8/1

Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children

Cell Reports Medicine

Andre G Costa-Martins

Karim Mane

Benjamin B Lindsey

Rodrigo LT Ogava

Ícaro Castro

...

2021/12/21

Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children

Clinical & Experimental Immunology

Megan E Cole

Rhiannon Kundu

Amina F Abdulla

Nicholas Andrews

Katja Hoschler

...

2021/4

Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity

Journal of Experimental Medicine

Chloe J Pyle

Lucia Labeur-Iurman

Helen T Groves

Franz Puttur

Clare M Lloyd

...

2021/10/19

See List of Professors in Dr John S Tregoning University(Imperial College London)

Co-Authors

academic-engine